# Fruquintinib vs Bevacizumab Combined With Irinotecan Liposome and Capecitabine as Second-Line Therapy for Advanced Metastatic Colorectal Cancer

Source: https://onco.cc/trials/nct07051785/  
OnCo record `nct07051785` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of fruquintinib, capecitabine and bevacizumab (glioblastoma use) in colorectal cancer, run by Liu Huang, not yet recruiting.

## Summary

Fruquintinib vs Bevacizumab Combined With Irinotecan Liposome and Capecitabine as Second-Line Therapy for Advanced Metastatic Colorectal Cancer is a phase 2, randomised interventional study registered as NCT07051785 by Liu Huang, with a registry enrolment figure of 68 participants, started 2025-07-07 and due to reach its primary completion in 2027-07-06. Interventions recorded: Fruquintinib+Irinotecan Liposome+Capecitabine; Bevacizumab+Irinotecan Liposome+Capecitabine. Conditions listed: Colorectal Cancer (CRC). Primary outcome: Progression-free Survival (PFS). Colorectal eligibility wording from the registry: "Patients with metastatic colorectal adenocarcinoma confirmed by pathology or histology;". No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Also known as: ARK
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT07051785
- Phase: 2
- Setting: Fruquintinib vs Bevacizumab Combined With Irinotecan Liposome and Capecitabine as Second-Line Therapy for Advanced Metastatic Colorectal Cancer：A Multicenter Randomized Controlled Trial
- Sponsor: Liu Huang
- Enrolled: 68

## Sources

- ClinicalTrials.gov NCT07051785: https://clinicaltrials.gov/study/NCT07051785

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/), [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- technologies: [Anti-angiogenic therapy](https://onco.cc/technologies/antiangiogenic/), [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Small-molecule kinase inhibitors](https://onco.cc/technologies/kinase-inhibitors/)
- drugs: [Bevacizumab (glioblastoma use)](https://onco.cc/drugs/bevacizumab-glioma/), [Capecitabine](https://onco.cc/drugs/capecitabine/), [Fruquintinib](https://onco.cc/drugs/fruquintinib/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07051785.json